SeqOne Genomics Appoints Hervé Pouzoullic as Chief Commercial Officer
SeqOne Genomics, provider of next generation genomic analysis solutions for personalized medicine, announces the appointment of Hervé Pouzoullic as Chief Commercial Officer (CCO).
- SeqOne Genomics, provider of next generation genomic analysis solutions for personalized medicine, announces the appointment of Hervé Pouzoullic as Chief Commercial Officer (CCO).
- He will lead the commercial development of the company to accelerate its growth and strengthen its international presence.
- "I am honored to join SeqOne to build a sales team with international ambitions and look forward to promoting innovative solutions that enable access to personalized medicine, for people living with cancer and rare diseases," said Hervé Pouzoullic CCO of SeqOne Genomics.
- said Nicolas Philippe, CEO and co-founder of SeqOne Genomics.